The low dose (7.5 mg/day) pioglitazone is beneficial to the improvement in metabolic parameters without weight gain and an increase of risk for heart failure

被引：10

作者：

Adachi, Hiroki ^{[1
,2
,3
]}

Katsuyama, Hisayuki ^{[1
,2
,3
]}

Yanai, Hidekatsu ^{[1
,2
,3
]}

机构：

[1] Natl Ctr Global Hlth, Dept Internal Med, 1-7-1 Kohnocai, Chiba 2728516, Japan

[2] Med Kohnodai Hosp, 1-7-1 Kohnocai, Chiba 2728516, Japan

[3] Natl Ctr Global Hlth & Med, Clin Res Ctr, 1-7-1 Kohnocai, Chiba 2728516, Japan

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2017年 / 227卷

关键词：

B-type natriuretic peptide; Body weight gain; Heart Failure; Pioglitazone; THIAZOLIDINEDIONES;

D O I：

10.1016/j.ijcard.2016.11.126

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：247 / 248

页数：2

共 6 条

[1] Brain natriuretic peptide: Much more than a biomarker
Calzetta, Luigino
Orlandi, Augusto
Page, Clive
Rogliani, Paola
Rinaldi, Barbara
Rosano, Giuseppe
Cazzola, Mario
Matera, Maria Gabriella
[J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 221 : 1031 - 1038
[2] Pioglitazone induces regression of coronary atherosclerotic plaques in patients with type 2 diabetes mellitus or impaired glucose tolerance: A randomized prospective study using intravascular ultrasound
Nakayama, Takashi
Komiyama, Nobuyuki
Yokoyama, Masaki
Namikawa, Susumu
Kuroda, Nakabumi
Kobayashi, Yoshio
Komuro, Issei
[J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 138 (02) : 157 - 165
[3] Thiazolidinedione use, fluid retention, and congestive heart failure - A consensus statement from the American Heart Association and American Diabetes Association
Nesto, RW
Bell, D
Bonow, RO
Fonseca, V
Grundy, SM
Horton, ES
Le Winter, M
Porte, D
Semenkovich, CF
Smith, S
Young, LH
Kahn, R
[J]. CIRCULATION, 2003, 108 (23) : 2941 - 2948
[4] Effect of low dose pioglitazone on glycemic control and insulin resistance in Type 2 diabetes: A randomized, double blind, clinical trial
Rajagopalan, Sujit
Dutta, Pinaki
Hota, Debasish
Bhansali, Anil
Srinivasan, Anand
Chakrabarti, Amitava
[J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 109 (03) : E32 - E35
[5] The controversial effects of thiazolidinediones on cardiovascular morbidity and mortality
Stafylas, Panagiotis C.
Sarafidis, Pantelis A.
Lasaridis, Anastasios N.
[J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 131 (03) : 298 - 304
[6] Drug therapy: Thiazolidinediones
Yki-Jarvinen, H
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (11) : 1106 - 1118

← 1 →